These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 24931662)

  • 1. The clinical use of plasma clozapine levels in a maximum security setting.
    Bennett DM; Bremner M; Gray C
    Int J Psychiatry Clin Pract; 2008; 12(3):228-34. PubMed ID: 24931662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-admissions to the State Hospital at Carstairs, 1992-1997.
    Duncan JM; Short A; Lewis JS; Barrett PT
    Health Bull (Edinb); 2002 Jan; 60(1):70-82. PubMed ID: 12664772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report.
    de Leon J; Diaz FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1059-63. PubMed ID: 14499324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the use of clozapine levels to guide treatment and determine cause of death.
    Stark A; Scott J
    Aust N Z J Psychiatry; 2012 Sep; 46(9):816-25. PubMed ID: 22327098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing clozapine treatment.
    Nielsen J; Damkier P; Lublin H; Taylor D
    Acta Psychiatr Scand; 2011 Jun; 123(6):411-22. PubMed ID: 21534935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of determining clozapine plasma level in follow-up of schizophrenic patients].
    Vailleau JL; Jeanny B; Chomard P; Vincent R
    Encephale; 1996; 22(2):103-9. PubMed ID: 8706619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of clozapine in serum of patients with schizophrenia as a measurement of medication compliance.
    Mennickent S; Sobarzo A; Vega M; de Diego M; Godoy G; Rioseco P; Saavedra L
    Int J Psychiatry Clin Pract; 2010 Mar; 14(1):41-6. PubMed ID: 24917231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
    Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
    Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients.
    Tassaneeyakul W; Kittiwattanagul K; Vannaprasaht S; Kampan J; Tawalee A; Puapairoj P; Tiamkao S; Juthagridsada S; Kukongviriyapan V; Tassaneeyakul W
    J Pharm Pharm Sci; 2005 Feb; 8(1):47-53. PubMed ID: 15946597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing and monitoring clozapine in Christchurch.
    McKean A; Vella-Brincat J; Begg E
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
    Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
    J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between clozapine plasma levels and withdrawal symptoms].
    Berecz R; de la Rubia Martínez A; Norberto Gamero MJ; Gutiérrez Casares JR; Glaub T; Degrell I; Llerena A
    Actas Esp Psiquiatr; 2002; 30(6):397-9. PubMed ID: 12487951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases in C-reactive protein may predict recurrence of clozapine-induced fever.
    Kohen I; Afzal N; Hussain S; Manu P
    Ann Pharmacother; 2009 Jan; 43(1):143-6. PubMed ID: 19126823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)].
    Ackenheil M; Bräu H; Burkhart A; Franke A; Pacha W
    Arzneimittelforschung; 1976; 26(6):1156-8. PubMed ID: 989406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
    Potkin SG; Bera R; Gulasekaram B; Costa J; Hayes S; Jin Y; Richmond G; Carreon D; Sitanggan K; Gerber B
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.